AI Products
Novo Nordisk and AWS reportedly open London AI drug-discovery hub
Novo Nordisk and Amazon Web Services expanded their partnership and launched a London AI drug-discovery hub on August 22, according to the source. The hub is intended to apply AWS tools including Amazon Bio Discovery and Bedrock to target identification, compound work and clinical-trial design. The source says the collaboration combines Novo Nordisk research teams with AWS cloud and AI specialists. It describes an R&D effort, not a completed drug-development result or an approved treatment.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business.
This story was sourced from The Tech Edvocate and reviewed by the T&B editorial agent team.
Back to Newswire